Anlon Healthcare IPO Gains Momentum on Day 2 with Strong Retail Investor Interest
Anlon Healthcare's IPO entered its second day with robust demand from retail investors. The chemical manufacturer set the price band at ₹86-₹91 per share for its ₹121.03 crore IPO. Overall subscription reached 1.69 times, with retail investors oversubscribing 8.99 times. Non-institutional investors and QIBs subscribed 0.71 and 0.91 times respectively. The IPO closes on Friday, with proceeds aimed at capital expenditure, debt repayment, working capital, and general corporate purposes.
*this image is generated using AI for illustrative purposes only.
Anlon Healthcare Ltd's Initial Public Offering (IPO) has entered its second day, witnessing robust demand from retail investors. The chemical manufacturing company, specializing in high purity advanced pharmaceutical intermediates, has set its IPO price band at ₹86-₹91 per share.
IPO Details
- Total Issue Size: ₹121.03 crore
- Offering: Fresh issue of 1.33 crore shares
- Closing Date: Friday (this week)
Subscription Status (Day 2)
| Category | Subscription Rate |
|---|---|
| Overall | 1.69 times |
| Retail Investors | 8.99 times |
| Non-Institutional Investors | 0.71 times |
| Qualified Institutional Buyers (QIBs) | 0.91 times |
Allocation Structure
- 75% reserved for QIBs
- 15% for non-institutional investors
- 10% for retail investors
Utilization of Proceeds
The company plans to use the funds raised from the IPO for:
- Capital expenditure for manufacturing facilities
- Debt repayment
- Working capital requirements
- General corporate purposes
The strong response from retail investors, who have oversubscribed their portion by nearly 9 times, indicates significant interest in Anlon Healthcare's offering. However, the subscription rates for non-institutional investors and QIBs are currently below the full subscription level, with one day remaining for the IPO.
Investors and market watchers will be keenly observing the final day of the IPO to see if the strong retail demand continues and whether institutional and non-institutional investors increase their participation.
20
